Abstract：It has been recognized that pertussis is a disease that affects all age groups. There are obvious limitations in the currently used diagnostic criteria with "one-size-fits-all" definition, which is not advantageous to start individual treatment and perform strategies for preventing the transmission. Therefore, the expert group of Global Pertussis Initiative gives a suggestion for the diagnosis of pertussis. Based on the related published studies, the present article analyzes the limitations of the current criteria, and introduces the GPI's suggestion in detail.
Cherry JD, Tan T, Wirsing von König CH, et al. Clinical definitions of pertussis:Summary of a Global Pertussis Initiative roundtable meeting, February 2011[J]. Clin Infect Dis, 2012, 54(12):1756-1764.
[2]
Forsyth KD, Wirsing von Konig CH, Tan T, et al. Prevention of pertussis:recommendations derived from the second Global Pertussis Initiative roundtable meeting[J]. Vaccine, 2007, 25(14):2634-2642.
[3]
World Health Organization; Dept. of Vaccines and Biologicals. WHO-recommended standards for surveillance of selected vaccine-preventable diseases[EB/OL]. (February 2003).
[4]
Centers for Disease Control and Prevention (CDC). Manual for the Surveillance of Vaccine-Preventable Diseases:Chapter 10:Pertussis[EB/OL]. (January 1, 2014).
Cherry JD. Epidemic pertussis in 2012-the resurgence of a vaccine-preventable disease[J]. N Engl J Med, 2012, 367(9):785-787.
[10]
Cherry JD, Grimprel E, Guiso N, et al. Defining pertussis epidemiology:clinical, microbiologic and serologic perspectives[J]. Pediatr Infect Dis J, 2005, 24(5 Suppl):S25-S34.
[11]
Koh MT, Liu CS, Chiu CH, et al. Under-recognized pertussis in adults from Asian countries:a cross-sectional seroprevalence study in Malaysia, Taiwan and Thailand[J]. Epidemiol Infect, 2016, 144(6):1192-1200.
[12]
He H, Yao P, Zhou Y, et al. Is pertussis infection neglected in China? Evidence from a seroepidemiology survey in Zhejiang,an eastern province of China[J]. PLoS One, 2016, 11(5):e0155965.
[13]
Chen Z, Zhang J, Cao L, et al. Seroprevalence of pertussis among adults in China where whole cell vaccines have been used for 50 years[J]. J Infect, 2016, 73(1):38-44.
[14]
Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies[J]. Clin Microbiol Rev, 2005, 18(2):326-382.
[15]
Schmitt-Grohé S, Cherry JD, Heininger U, et al. Pertussis in German adults[J]. Clin Infect Dis, 1995, 21(4):860-866.
[16]
Huygen K, Rodeghiero C, Govaerts D, et al. Bordetella pertussis seroprevalence in Belgian adults aged 20-39 years, 2012[J]. Epidemiol Infect, 2014, 142(4):724-728.
[17]
Guiso N, Berbers G, Fry NK, et al. What to do and what not to do in serological diagnosis of pertussis:recommendations from EU reference laboratories[J]. Eur J Clin Microbiol Infect Dis, 2011, 30(3):307-312.
[18]
Ghanaie RM, Karimi A, Sadeghi H, et al. Sensitivity and specificity of the World Health Organization pertussis clinical case definition[J]. Int J Infect Dis, 2010, 14(12):e1072-e1075.
[19]
Strebel P, Nordin J, Edwards K, et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996[J]. J Infect Dis, 2001, 183(9):1353-1359.
[20]
Miyashita N, Akaike H, Teranishi H, et al. Diagnostic value of symptoms and laboratory data for pertussis in adolescent and adult patients[J]. BMC Infect Dis, 2013, 13:129.
[21]
Nieves DJ, Singh J, Ashouri N, et al. Clinical and laboratory features of pertussis in infants at the onset of a California epidemic[J]. J Pediatr, 2011, 159(6):1044-1046.
[22]
Shojaei J, Saffar M, Hashemi A, et al. Clinical and laboratory features of pertussis in hospitalized infants with confirmed versus probable pertussis cases[J]. Ann Med Health Sci Res, 2014, 4(6):910-914.
[23]
Patriarca PA, Biellik RJ, Sanden G, et al. Sensitivity and specificity of clinical case definitions for pertussis[J]. Am J Public Health, 1988, 78(7):833-836.
[24]
Stehr K, Cherry JD, Heininger U, et al. A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine[J]. Pediatrics, 1998, 101(1 Pt 1):1-11.
